使用促红细胞生成素治疗终末期肾病中的贫血。
The use of erythropoietin to treat anaemia in end-stage renal disease.
作者信息
Ellis P, Ellis J A
出版信息
Prof Nurse. 1995 Apr;10(7):448-50.
PMID:7724635
Abstract
Recombinant human erythropoietin (r-HuEPO) has greatly improved the lives of renal patients with anaemia. Nurses who administer r-HuEPO should be aware of its side-effects. Studies are still needed to elicit the most efficient route of administration of r-HuEPO.
摘要
重组人促红细胞生成素（r-HuEPO）极大地改善了贫血肾病患者的生活。使用r-HuEPO的护士应了解其副作用。仍需开展研究以找出r-HuEPO最有效的给药途径。
Zotero 插件